Lv Q - Search Results

1

Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery.

Lv Q, Yu A, Xi Y, Li H, Song Z, Cui J, Cao F, Zhai G. Lv Q, et al. Int J Pharm. 2009 May 8;372(1-2):191-8. doi: 10.1016/j.ijpharm.2009.01.014. Epub 2009 Jan 22. Int J Pharm. 2009. PMID: 19429280

2

Cell penetrating peptide TAT-functionalized liposomes for efficient ophthalmic delivery of flurbiprofen: Penetration and its underlying mechanism, retention, anti-inflammation and biocompatibility.

Wu B, Li M, Li K, Hong W, Lv Q, Li Y, Xie S, Han J, Tian B. Wu B, et al. Among authors: lv q. Int J Pharm. 2021 Apr 1;598:120405. doi: 10.1016/j.ijpharm.2021.120405. Epub 2021 Feb 26. Int J Pharm. 2021. PMID: 33647409

3

Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.

Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q, Li K. Gao S, et al. Among authors: lv q. Int J Nanomedicine. 2019 Aug 2;14:6135-6150. doi: 10.2147/IJN.S205295. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31447556 Free PMC article.

4

Improved antitumor activity and tolerability of cabazitaxel derived remote-loading liposomes.

Yang Z, Chi D, Wang Q, Guo X, Lv Q, Wang Y. Yang Z, et al. Among authors: lv q. Int J Pharm. 2020 Nov 15;589:119814. doi: 10.1016/j.ijpharm.2020.119814. Epub 2020 Aug 30. Int J Pharm. 2020. PMID: 32877728

5

Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers.

Li K, Gao S, Tian B, Shi Y, Lv Q, Han J. Li K, et al. Among authors: lv q. Curr Drug Deliv. 2018;15(3):424-435. doi: 10.2174/1567201815666171207163010. Curr Drug Deliv. 2018. PMID: 29219057

6

Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate.

Lv Q, Yang J, Zhang R, Yang Z, Yang Z, Wang Y, Xu Y, He Z. Lv Q, et al. Mol Pharm. 2018 May 7;15(5):1842-1852. doi: 10.1021/acs.molpharmaceut.8b00026. Epub 2018 Apr 5. Mol Pharm. 2018. PMID: 29608845

7

GSH-Responsive Prodrug Nanoassembly as a Carrier-Free Nanoplatform for Tumor-Targeting Delivery and Chemo-Photothermal Therapy.

Tian B, Xu H, Wang H, Li K, Zheng S, Hu S, Wang Y, Lv Q. Tian B, et al. Among authors: lv q. Mol Pharm. 2023 Aug 7;20(8):4210-4218. doi: 10.1021/acs.molpharmaceut.3c00319. Epub 2023 Jul 18. Mol Pharm. 2023. PMID: 37463505

8

Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy.

Wang Y, Yu J, Li D, Zhao L, Sun B, Wang J, Wang Z, Zhou S, Wang M, Yang Y, Liu H, Zhang H, Lv Q, Jiang Q, He Z, Wang Y. Wang Y, et al. Among authors: lv q. J Control Release. 2022 Jan;341:812-827. doi: 10.1016/j.jconrel.2021.12.023. Epub 2021 Dec 23. J Control Release. 2022. PMID: 34953979

9

Oral delivery of human growth hormone: Preparation, characterization, and pharmacokinetics.

Shi Y, Li K, Tian B, Xu M, Lv Q, Zhao J, Han J, Feng D. Shi Y, et al. Among authors: lv q. J Biomater Appl. 2017 Jan;31(6):851-858. doi: 10.1177/0885328216674347. Epub 2016 Oct 14. J Biomater Appl. 2017. PMID: 27742865

10

High Co-loading Capacity and Stimuli-Responsive Release Based on Cascade Reaction of Self-Destructive Polymer for Improved Chemo-Photodynamic Therapy.

Wang M, Zhai Y, Ye H, Lv Q, Sun B, Luo C, Jiang Q, Zhang H, Xu Y, Jing Y, Huang L, Sun J, He Z. Wang M, et al. Among authors: lv q. ACS Nano. 2019 Jun 25;13(6):7010-7023. doi: 10.1021/acsnano.9b02096. Epub 2019 Jun 12. ACS Nano. 2019. PMID: 31188559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,826 results

Search Page

Filters